584 related articles for article (PubMed ID: 25362362)
1. A robust pipeline for rapid production of versatile nanobody repertoires.
Fridy PC; Li Y; Keegan S; Thompson MK; Nudelman I; Scheid JF; Oeffinger M; Nussenzweig MC; Fenyö D; Chait BT; Rout MP
Nat Methods; 2014 Dec; 11(12):1253-60. PubMed ID: 25362362
[TBL] [Abstract][Full Text] [Related]
2. Generation of mWasabi fluorescent protein-binding nanobodies.
Li S; Shan H; Wang T; Zheng X; Shi M; Chen B; Lu H; Zhang Y; Zhao S; Hua Z
Anal Biochem; 2020 Nov; 608():113875. PubMed ID: 32739350
[TBL] [Abstract][Full Text] [Related]
3. Characterization of camel nanobodies specific for superfolder GFP fusion proteins.
Twair A; Al-Okla S; Zarkawi M; Abbady AQ
Mol Biol Rep; 2014 Oct; 41(10):6887-98. PubMed ID: 25085037
[TBL] [Abstract][Full Text] [Related]
4. Streamlined method for parallel identification of single domain antibodies to membrane receptors on whole cells.
Rossotti M; Tabares S; Alfaya L; Leizagoyen C; Moron G; González-Sapienza G
Biochim Biophys Acta; 2015 Jul; 1850(7):1397-404. PubMed ID: 25819371
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of nanobodies against rhGH expressed as sfGFP fusion protein.
Abbady AQ; Al-Shemali R; Mir Assaad J; Murad H
Gen Comp Endocrinol; 2014 Aug; 204():33-42. PubMed ID: 24859761
[TBL] [Abstract][Full Text] [Related]
6. Development and production of nanobodies specifically against green fluorescence protein.
Fang Z; Cao D; Qiu J
Appl Microbiol Biotechnol; 2020 Jun; 104(11):4837-4848. PubMed ID: 32270250
[TBL] [Abstract][Full Text] [Related]
7. Engineering and characterization of GFP-targeting nanobody: Expression, purification, and post-translational modification analysis.
Weng D; Yang L; Xie Y
Protein Expr Purif; 2024 Sep; 221():106501. PubMed ID: 38782081
[TBL] [Abstract][Full Text] [Related]
8. Nanobody production can be simplified by direct secretion from Escherichia coli.
Iwaki T; Hara K; Umemura K
Protein Expr Purif; 2020 Jun; 170():105607. PubMed ID: 32062022
[TBL] [Abstract][Full Text] [Related]
9. Characterization and comparison of two peptide-tag specific nanobodies for immunoaffinity chromatography.
Ren J; Zhang C; Ji F; Jia L
J Chromatogr A; 2020 Aug; 1624():461227. PubMed ID: 32540069
[TBL] [Abstract][Full Text] [Related]
10. Development, Screening, and Validation of Camelid-Derived Nanobodies for Neuroscience Research.
Gavira-O'Neill CE; Dong JX; Trimmer JS
Curr Protoc Neurosci; 2020 Dec; 94(1):e107. PubMed ID: 33185319
[TBL] [Abstract][Full Text] [Related]
11. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
12. Unravelling the Molecular Basis of High Affinity Nanobodies against HIV p24: In Vitro Functional, Structural, and in Silico Insights.
Gray ER; Brookes JC; Caillat C; Turbé V; Webb BLJ; Granger LA; Miller BS; McCoy LE; El Khattabi M; Verrips CT; Weiss RA; Duffy DM; Weissenhorn W; McKendry RA
ACS Infect Dis; 2017 Jul; 3(7):479-491. PubMed ID: 28591513
[TBL] [Abstract][Full Text] [Related]
13. Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein.
El-Turk F; Newby FN; De Genst E; Guilliams T; Sprules T; Mittermaier A; Dobson CM; Vendruscolo M
Biochemistry; 2016 Jun; 55(22):3116-22. PubMed ID: 27096466
[TBL] [Abstract][Full Text] [Related]
14. Characterization and applications of Nanobodies against human procalcitonin selected from a novel naïve Nanobody phage display library.
Yan J; Wang P; Zhu M; Li G; Romão E; Xiong S; Wan Y
J Nanobiotechnology; 2015 May; 13():33. PubMed ID: 25944262
[TBL] [Abstract][Full Text] [Related]
15. Llama immunization with full-length VAR2CSA generates cross-reactive and inhibitory single-domain antibodies against the DBL1X domain.
Nunes-Silva S; Gangnard S; Vidal M; Vuchelen A; Dechavanne S; Chan S; Pardon E; Steyaert J; Ramboarina S; Chêne A; Gamain B
Sci Rep; 2014 Dec; 4():7373. PubMed ID: 25487735
[TBL] [Abstract][Full Text] [Related]
16. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
17. A genetically encoded toolkit of functionalized nanobodies against fluorescent proteins for visualizing and manipulating intracellular signalling.
Prole DL; Taylor CW
BMC Biol; 2019 May; 17(1):41. PubMed ID: 31122229
[TBL] [Abstract][Full Text] [Related]
18. Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.
Van Audenhove I; Boucherie C; Pieters L; Zwaenepoel O; Vanloo B; Martens E; Verbrugge C; Hassanzadeh-Ghassabeh G; Vandekerckhove J; Cornelissen M; De Ganck A; Gettemans J
FASEB J; 2014 Apr; 28(4):1805-18. PubMed ID: 24414419
[TBL] [Abstract][Full Text] [Related]
19. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
20. Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain.
Rossotti MA; González-Techera A; Guarnaschelli J; Yim L; Camacho X; Fernández M; Cabral P; Leizagoyen C; Chabalgoity JA; González-Sapienza G
MAbs; 2015; 7(5):820-8. PubMed ID: 26192995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
